252 related articles for article (PubMed ID: 37841249)
1. Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review.
Li H; Zhang L; Yang F; Zhao R; Li X; Li H
Front Immunol; 2023; 14():1218386. PubMed ID: 37841249
[TBL] [Abstract][Full Text] [Related]
2. The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
Zhang Y; Chen H; Chen S; Li Z; Chen J; Li W
Oncoimmunology; 2021; 10(1):1957605. PubMed ID: 34377596
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Liu C; Wei W; Yang L; Li J; Yi C; Pu Y; Yin T; Na F; Zhang L; Fu P; Zhao Y
Front Immunol; 2023; 14():1173952. PubMed ID: 37313406
[TBL] [Abstract][Full Text] [Related]
4. Effect of renin-angiotensin-aldosterone system inhibitors on survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Shen J; Hou H; Liang B; Guo X; Chen L; Yang Y; Wang Y
Front Immunol; 2023; 14():1155104. PubMed ID: 37153578
[TBL] [Abstract][Full Text] [Related]
5. The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature.
Fejza A; Carobolante G; Poletto E; Camicia L; Schinello G; Di Siena E; Ricci G; Mongiat M; Andreuzzi E
Front Immunol; 2023; 14():1270981. PubMed ID: 37854588
[TBL] [Abstract][Full Text] [Related]
6. The negative effect of concomitant medications on immunotherapy in non-small cell lung cancer: An umbrella review.
Chen J; Chen S; Luo H; Long S; Yang X; He W; Wu W; Wang S
Int Immunopharmacol; 2023 Nov; 124(Pt B):110919. PubMed ID: 37722262
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice.
Cortellini A; Tucci M; Adamo V; Stucci LS; Russo A; Tanda ET; Spagnolo F; Rastelli F; Bisonni R; Santini D; Russano M; Anesi C; Giusti R; Filetti M; Marchetti P; Botticelli A; Gelibter A; Occhipinti MA; Marconcini R; Vitale MG; Nicolardi L; Chiari R; Bareggi C; Nigro O; Tuzi A; De Tursi M; Petragnani N; Pala L; Bracarda S; Macrini S; Inno A; Zoratto F; Veltri E; Di Cocco B; Mallardo D; Vitale MG; Pinato DJ; Porzio G; Ficorella C; Ascierto PA
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33154150
[TBL] [Abstract][Full Text] [Related]
8. Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis.
Tian BW; Han CL; Wang HC; Yan LJ; Ding ZN; Liu H; Mao XC; Tian JC; Xue JS; Yang LS; Tan SY; Dong ZR; Yan YC; Wang DX; Li T
Clin Exp Metastasis; 2023 Aug; 40(4):255-287. PubMed ID: 37308706
[TBL] [Abstract][Full Text] [Related]
9. The negative impact of opioids on cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Ju M; Gao Z; Liu X; Zhou H; Wang R; Zheng C; Dong D; Zhu Z; Li K
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2699-2708. PubMed ID: 36538147
[TBL] [Abstract][Full Text] [Related]
10. An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis.
Liu C; Guo H; Mao H; Tong J; Yang M; Yan X
Front Oncol; 2022; 12():753234. PubMed ID: 35280736
[TBL] [Abstract][Full Text] [Related]
11. Effect of Concomitant Use of Analgesics on Prognosis in Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Mao Z; Jia X; Jiang P; Wang Q; Zhang Y; Li Y; Fu X; Jiao M; Jiang L; Liu Z; Guo H
Front Immunol; 2022; 13():861723. PubMed ID: 35603146
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint inhibitors related respiratory disorders in patients with lung cancer: A meta-analysis of randomized controlled trials.
Liu H; Luo SX; Jie J; Peng L; Wang S; Song L
Front Immunol; 2023; 14():1115305. PubMed ID: 36926326
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database.
Chen P; Zhu J; Xu Y; Huang Q; Su J; Gao Z; Feng M
BMC Nephrol; 2023 Apr; 24(1):107. PubMed ID: 37087434
[TBL] [Abstract][Full Text] [Related]
14. The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis.
Chang Y; Lin WY; Chang YC; Huang CH; Tzeng HE; Abdul-Lattif E; Wang TH; Tseng TH; Kang YN; Chi KY
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612290
[TBL] [Abstract][Full Text] [Related]
15. A Network Comparison on Safety Profiling of Immune Checkpoint Inhibitors in Advanced Lung Cancer.
Yan YD; Cui JJ; Fu J; Su YJ; Chen XY; Gu ZC; Lin HW
Front Immunol; 2021; 12():760737. PubMed ID: 34925331
[TBL] [Abstract][Full Text] [Related]
16. Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis.
Sun Q; Sun H; Wu N; Hu Y; Zhang F; Cong X
Front Oncol; 2022; 12():976224. PubMed ID: 36185176
[TBL] [Abstract][Full Text] [Related]
17. The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors.
Zhang L; Chen C; Chai D; Li C; Guan Y; Liu L; Kuang T; Deng W; Wang W
Front Immunol; 2022; 13():956533. PubMed ID: 36059512
[TBL] [Abstract][Full Text] [Related]
18. Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis.
Zhang L; Wang H; Tian J; Sui L; Chen X
Int J Clin Pract; 2022; 2022():3429462. PubMed ID: 35855055
[TBL] [Abstract][Full Text] [Related]
19. How to Choose a Survival Period? The Impact of Antibiotic Use on OS or PFS in NSCLC Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Chen H; Han KD; He ZJ; Huang YS
Technol Cancer Res Treat; 2021; 20():15330338211033498. PubMed ID: 34323149
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
